Logotype for Magnera Corporation

Magnera (MAGN) Q1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Magnera Corporation

Q1 2025 earnings summary

8 Jul, 2026

Executive summary

  • Completed the merger of Berry Global's nonwovens and hygiene films business with Glatfelter on November 4, 2024, forming Magnera, a global leader in personal care and consumer solutions with two segments: Americas and Rest of World, serving over 1,000 customers across 46 facilities and employing approximately 9,000 people.

  • Fiscal Q1 2025 marked Magnera's official launch, with results exceeding prior year despite FX headwinds, integration activities, and challenging market conditions.

  • Focused on integration, cost-saving initiatives, and delivering on synergy commitments, with a three-year plan targeting $55 million in net synergies.

  • Emphasized sustainability, innovation, and a broad product portfolio across personal care, consumer solutions, hygiene, healthcare, wipes, construction, and food and beverage sectors.

  • Operating loss increased to $22 million from $12 million year-over-year, impacted by integration costs, inventory step-up, and currency effects; net loss widened to $60 million from $8 million.

Financial highlights

  • Q1 2025 net sales rose 35% year-over-year to $702 million, driven by the merger and higher selling prices; Americas $420 million, Rest of World $282 million.

  • Adjusted EBITDA increased 8% year-over-year to $84 million, with margin up 68 basis points to 12%.

  • Free cash flow post-merger was $16 million for the quarter; cash and cash equivalents at quarter end were $215 million.

  • Basic and diluted EPS: $(1.69) (vs. $(0.25) prior year); operating margin negative due to integration and transaction costs.

  • Net debt to pro forma Adjusted EBITDA at quarter-end was 4x, with total net debt at $1.78 billion.

Outlook and guidance

  • Fiscal 2025 adjusted EBITDA guidance set at $385–$405 million, with post-merger adjusted free cash flow projected at $75–$95 million and $85 million in capital expenditures.

  • FY25 midpoint guidance targets 7% year-over-year comparable earnings growth.

  • Annual synergy realization from the GLT transaction expected to reach $55 million net of incremental standalone costs.

  • Focus on deleveraging, with incremental $70 million free cash flow expected for the remainder of the year.

  • Working capital modeled as flat for 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more